Medprin Regenerative Medical Technologies Co., Ltd.
Clinical trials sponsored by Medprin Regenerative Medical Technologies Co., Ltd., explained in plain language.
A Chinese company specializing in regenerative medical products and biomaterials.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Can a dissolvable glue seal the brain and stop leaks after surgery?
Disease control CompletedThis clinical trial is testing whether a new absorbable adhesive can help seal the protective lining of the brain (the dura) after neurosurgery, preventing cerebrospinal fluid leaks. The study involves 132 adults who are having brain or spinal surgery and are at risk of such leak…
Phase 3 • Sponsor: Medprin Regenerative Medical Technologies Co., Ltd. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a new dissolvable dressing stop surgical bleeding faster?
Disease control CompletedThis trial is testing whether a new absorbable dressing made from oxidized cellulose can safely and effectively stop bleeding during surgery. The study will compare it to a standard hemostatic dressing in about 288 adults undergoing various surgical procedures. The main goal is t…
Phase 3 • Sponsor: Medprin Regenerative Medical Technologies Co., Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a glue stop spinal fluid leaks after surgery?
Disease control CompletedThis trial tests whether a special medical adhesive can create a watertight seal over the spinal lining after surgery, preventing cerebrospinal fluid leaks. About 141 adults undergoing spinal surgery with confirmed fluid leakage will be randomly assigned to receive either the adh…
Phase 3 • Sponsor: Medprin Regenerative Medical Technologies Co., Ltd. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New device quickly stops bleeding in brain surgery
Disease control CompletedThis study looked at a medical device called StypCel™ that helps stop bleeding during brain surgery. It included 108 patients between 18 and 75 years old. The main goal was to see how quickly the device stopped bleeding and to check its safety in real-world use.
Sponsor: Medprin Regenerative Medical Technologies Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC